3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
8
Glioma
3
Breast Neoplasms
3
Brain Neoplasms
3
Thyroid Neoplasms
2
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Neoplasms
1
Thyroid Nodule
1
Thrombocythemia, Essential
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Retinoblastoma
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Polycythemia Vera
1
Interventions
Bevacizumab
9
pembrolizumab
5
lenvatinib
5
durvalumab
5
atezolizumab
5
tremelimumab
3
fludarabine
3
camrelizumab
3
apatinib
3
Ipilimumab
3
Cyclophosphamide
3
regorafenib
2
Riluzole
2
Radiotherapy
2
Nivolumab
2
Magnetic Resonance Imaging
2
Idarubicin
2
Blood Specimen Collection
2
Biopsy
2
yttrium chloride
1
trastuzumab deruxtecan
1
spartalizumab
1
sintilimab
1
pertuzumab
1
ferric carboxymaltose
1
epigallocatechin gallate
1
donafenib
1
cemiplimab
1
brodalumab
1
Yttrium-90
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Liver Neoplasms
×
Watchful Waiting
×
Clear all
NCT03253536
2017-08-18
LIVERCARE
Ludwig-Maximilians - University of Munich
Recruiting
100 enrolled